Certain Biomarkers Linked To Adverse Outcomes Among Patients With NAFLD And COVID-19, Researchers Find
May 24, 2021
Healio (5/21) reported, “Researchers found certain diagnostics linked to adverse outcomes among patients with non-alcoholic fatty liver disease during COVID-19, according to a presentation at Digestive Disease Week.” In this “retrospective study, research...